Literature DB >> 28105703

Mechanisms involved in enhancement of matrix metalloproteinase-9 expression in macrophages by interleukin-33.

Wataru Ariyoshi1, Toshinori Okinaga1, Wichida Chaweewannakorn1,2, Sumio Akifusa3, Tatsuji Nisihara1.   

Abstract

Endothelial transmigration of macrophages is accomplished by matrix metalloproteinase (MMP)-induced degradation of the basement membrane and extracellular matrix components. Macrophages upregulate MMP-9 expression and secretion upon immunological challenges and require its activity for migration during inflammatory responses. Interleukin (IL)-33 is a recently discovered pro-inflammatory cytokine that belongs to the IL-1 family. The aim of this study was to elucidate the mechanisms underlying IL-33-induced MMP-9 expression in the mouse monocyte/macrophage line RAW264.7. IL-33 increased MMP-9 mRNA and protein expression in RAW264.7 cells. Blockage of IL-33-IL-33 receptor (ST2L) binding suppressed IL-33-mediated induction of MMP-9. IL-33 induced phosphorylation and nuclear translocation of extracellular signal-regulated kinase 1/2 (ERK1/2) and nuclear factor-kappa B (NF-κB). Chromatin immunoprecipitation indicated that IL-33 increased c-fos recruitment to the MMP-9 promoter. Reporter assay findings also revealed that IL-33 stimulated the transcriptional activity of activator protein 1 (AP-1). Pre-treatment of the cells with a specific inhibitor of ERK1/2 and NF-κB attenuated the IL-33-induced activation of AP-1 subunits, transcriptional activity of AP-1, and expression of MMP-9. We also demonstrated that ERK-dependent activation of cAMP response element binding protein (CREB) is a key step for AP-1 activation by IL-33. These results indicate an essential role of ERK/CREB and NF-κB cascades in the induction of MMP-9 in monocytes/macrophages through AP-1 activation.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  activator protein 1 (AP-1); interleukin-33 (IL-33); macrophage; matrix metalloproteinase-9 (MMP-9); nuclear factor-kappa B (NF-κB)

Mesh:

Substances:

Year:  2017        PMID: 28105703     DOI: 10.1002/jcp.25809

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  8 in total

1.  Molecular mechanisms of IL-33-mediated stromal interactions in cancer metastasis.

Authors:  Patrik Andersson; Yunlong Yang; Kayoko Hosaka; Yin Zhang; Carina Fischer; Harald Braun; Shuzhen Liu; Guohua Yu; Shihai Liu; Rudi Beyaert; Mayland Chang; Qi Li; Yihai Cao
Journal:  JCI Insight       Date:  2018-10-18

Review 2.  Transcription factors regulated by cAMP in smooth muscle of the myometrium at human parturition.

Authors:  Jonathan K H Li; Pei F Lai; Rachel M Tribe; Mark R Johnson
Journal:  Biochem Soc Trans       Date:  2021-04-30       Impact factor: 5.407

3.  The invasiveness of human cervical cancer associated to the function of NaV1.6 channels is mediated by MMP-2 activity.

Authors:  Osbaldo Lopez-Charcas; Ana Maria Espinosa; Ana Alfaro; Zazil Herrera-Carrillo; Belen Ernestina Ramirez-Cordero; Pedro Cortes-Reynosa; Eduardo Perez Salazar; Jaime Berumen; Juan Carlos Gomora
Journal:  Sci Rep       Date:  2018-08-29       Impact factor: 4.379

4.  Elevated IL-33 promotes expression of MMP2 and MMP9 via activating STAT3 in alveolar macrophages during LPS-induced acute lung injury.

Authors:  Yafeng Liang; Nengli Yang; Guoquan Pan; Bingxin Jin; Shufen Wang; Wei Ji
Journal:  Cell Mol Biol Lett       Date:  2018-10-31       Impact factor: 5.787

Review 5.  The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine.

Authors:  Jean-Jacques Fournié; Mary Poupot
Journal:  Front Immunol       Date:  2018-10-26       Impact factor: 7.561

6.  Safranal Alleviates Dextran Sulfate Sodium-Induced Colitis and Suppresses Macrophage-Mediated Inflammation.

Authors:  Peeraphong Lertnimitphun; Yiwen Jiang; Nami Kim; Wenwei Fu; Changwu Zheng; Hongsheng Tan; Hua Zhou; Xue Zhang; Weizhong Pei; Yue Lu; Hongxi Xu
Journal:  Front Pharmacol       Date:  2019-11-01       Impact factor: 5.810

Review 7.  The Janus Face of IL-33 Signaling in Tumor Development and Immune Escape.

Authors:  Mi-Ran Choi; Jeffrey A Sosman; Bin Zhang
Journal:  Cancers (Basel)       Date:  2021-06-30       Impact factor: 6.639

Review 8.  The Pleiotropic Immunomodulatory Functions of IL-33 and Its Implications in Tumor Immunity.

Authors:  Claudia Afferni; Carla Buccione; Sara Andreone; Maria Rosaria Galdiero; Gilda Varricchi; Gianni Marone; Fabrizio Mattei; Giovanna Schiavoni
Journal:  Front Immunol       Date:  2018-11-13       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.